期刊文献+

尿β-D-半乳糖苷酶活性检测方法的建立及临床意义探讨 被引量:4

Establishment on the determination method of urinary beta-D-galactosidase activity
下载PDF
导出
摘要 目的以2-氯-4-硝基苯基-β-D-半乳糖苷(CNP-GAL)为底物,建立测定尿β-D-半乳糖苷酶(GAL)活性的连续监测法,并探讨GAL在肾小管病变早期诊断中的临床意义。方法基于GAL能催化水解底物生成色原2-氯-4-硝基苯酚(CNP)的原理,对最适p H值、底物浓度、反应时间等条件进行研究,建立用于检测尿GAL的连续监测法,并用该法检测125例肾脏病变(30例继发性肾损伤、36例肾小管肾炎、25例肾癌、34例肾囊肿)患者及80名健康体检者(正常对照组)尿GAL活性。结果建立了检测尿GAL活性的连续监测法,采用柠檬酸缓冲液为最佳缓冲体系,酶促反应最适p H值为4.8,最适底物浓度为2.0 mmol/L。该法批内、批间平均变异系数(CV)分别为2.44%、4.47%,线性范围为3.2~25.6 U/L,当GAL<1.6 U/L时不能被检出。继发性肾损伤、肾小管肾炎、肾癌患者的尿GAL活性均明显高于正常对照组(P<0.05),而肾囊肿患者的尿GAL活性无明显增高。结论建立的GAL活性连续监测法敏感性高,结果准确,操作简便,可用于肾小管疾病的早期诊断。 Objective To establish the continuous monitoring method for urinary beta-D-galactosidase (GAL)activity using 2-chloro-4-nitrophenyl-beta-D-galactosidase (CNP-GAL)as substrate,and to investigate the value of GAL in the early diagnosis of renal tubular lesion. Methods Based on the generation of color substance upon the hydrolysis of substrate into 2-chloro-4-nitrophenol(CNP),the optimal pH value,substrate concentration,reaction time and so on were analyzed. The continuous monitoring method for urinary GAL activity was established.Urinary GAL activities in renal tubular lesion patients(30 cases of secondary renal injury,36 cases of tubal nephritis,25 cases of renal carcinoma and 34 cases of renal cyst) and 80 healthy subjects (healthy control group)were determined. Results The continuous monitoring method for urinary GAL activity was established using citric acid buffer solution. The enzyme optimal pH value was 4.8,the optimal substrate concentration was 2.0 mmol/L,and the within-run and between-run coefficients of variation(CV)were 2.44% and 4.47%. The linear range was 3.2-25.6 U/L,which can not be determined at GAL<1.6 U/L. Urinary GAL activities in patients with secondary renal injury,tubal nephritis and renal carcinoma were higher than those in healthy control group(P<0.05),and there was no difference in renal cyst patients. Conclusions The continuous monitoring method for urinary GAL activity has good sensitivity,precision and simplicity,which is suitable for the early diagnosis of renal tubular lesion.
作者 宋云霄 邬建民 张建华 姚莉韵 SONG Yunxiao;WU Jianmin;ZHANG Jianhua;YAO Liyun(Department of Clinical Laboratory,Shanghai Xuhui Central Hospital,Shanghai 200031,China;Department of Clinical Laboratory,Shanghai Yangpu District Mental Health Center,Shanghai 200093,China;Department of Chemistry,Shanghai Jiaotong University School of Medicine,Shanghai 200025,China)
出处 《检验医学》 CAS 2017年第3期219-223,共5页 Laboratory Medicine
关键词 Β-D-半乳糖苷酶 2-氯-4-硝基苯基-β-D-半乳糖苷 连续监测法 肾小管病变 Beta-D-galactosidase 2-Chloro-4-nitrophenyl-beta-D-galactosidase Continuous monitoring method Renal tubular lesion
  • 相关文献

参考文献5

二级参考文献27

  • 1董向让,金仲品.糖尿病肾病早期标志物及其临床意义的研究进展[J].中国煤炭工业医学杂志,2005,8(3):205-206. 被引量:8
  • 2李稻.尿系列蛋白的免疫学检测及其临床意义[J].上海医学检验杂志,1996,11(4):251-252. 被引量:65
  • 3朱立华,刘静霞,洪健美.糖尿病早期肾病监控指标评价[J].北京医科大学学报,1997,29(2):176-177. 被引量:12
  • 4Trachtenberg F,Barregard L,McKinlay S.The influence of urinary flow rate in children on excretion of markers used for assessment of renal damage:albumin,γ-glutamyl transpeptidase,N-acetyl-β-D-glucosaminidase,alpha1-microglobulin[J].Pediatr Nephrol,2008,23(3):445-456.
  • 5Mink SN,Jacobs H,Duke K,et al.N,N',N"-triacetylglucosamine,an inhibitor of lysozyme,prevents myocardialdepression in Escherichia coli sepsis in dogs[J].Crit Care Med,2004,32(1):184-193.
  • 6Gessner C,Wirtz H,Sack U,et al.BALF N-acetylglucosaminidase and beta-galactosidase activities in idiopathic pulmonary fibrosis[J].Respir Med,2002,96(9):751-756.
  • 7Hosseini R,Dehpour AR,Rad MH,et al.An improved method for evaluation of nephrotoxicity by assay of urinary N -Acetyl-a'-D-glucosaminidase(NAG) activity[J].Toxicol Mech Methods,1997,7(3):153-176.
  • 8Chiaramonte C,Cigna RM,Cataliotti F.Microproteinuria as a marker of renal damage in children[J].Minerva Urol Nefrol,2002,54(4):237-242.
  • 9Loredana-Marcovecchio M,Neil-Dalton R,Toby-Prevost A,et al.Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type 1 diabetes[J].Diabetes Care,2009,32(4):658-663.
  • 10Aekplakorn W,Srivanichakorn S,Sangwatanaroj S.Microalbuminuria and metabolic risk factors in patients with type 2 diabetes in primary care setting in Thailand[J].Diabetes Res Clin Pract,2009,84(1):92-98.

共引文献120

同被引文献36

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部